Glaukos Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
GKOS New York 2830 www.glaukos.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Glaukos Corporation

Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29 - Apr 8th, 2026 5:00 am
Does Glaukos (GKOS) Using Epioxa at ASCRS Hint at a Broader Corneal-Health Strategy Shift? - Apr 6th, 2026 9:08 pm
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - Apr 6th, 2026 5:00 am
Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments - Mar 20th, 2026 7:33 am
Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report? - Mar 19th, 2026 9:30 am
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care - Mar 19th, 2026 5:00 am
Should Glaukos’ (GKOS) Big 2026 Sales Target and ESOP Shelf Filing Require Action From Investors? - Feb 26th, 2026 1:16 am
Strong Results with 38.1% Revenue Growth Lifted Glaukos (GKOS) in Q4 - Feb 23rd, 2026 6:28 am
Glaukos Corporation Q4 2025 Earnings Call Summary - Feb 19th, 2026 6:08 pm
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data - Feb 19th, 2026 3:41 pm
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead - Feb 19th, 2026 3:34 pm
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition - Feb 19th, 2026 3:23 pm
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale - Feb 19th, 2026 3:15 pm
BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider - Feb 19th, 2026 1:12 pm
Why Analysts See Glaukos (GKOS) Story Shifting As iDose Repeat Dosing Takes Center Stage - Feb 18th, 2026 9:36 pm
Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook - Feb 18th, 2026 8:53 am
Glaukos Corp (GKOS) Q4 2025 Earnings Call Highlights: Record Sales and Strong Growth Outlook - Feb 17th, 2026 10:01 pm
Glaukos Q4 Earnings Call Highlights - Feb 17th, 2026 8:34 pm
Glaukos (GKOS) Q4 2025 Earnings Call Transcript - Feb 17th, 2026 4:30 pm
Glaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to Say - Feb 17th, 2026 4:00 pm